Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ameritox invests in depression blood test with Ridge licensing deal

This article was originally published in Clinica

Executive Summary

Pain medication monitoring specialist Ameritox is branching out into depression after signing a deal that will allow it to sell Ridge Diagnostics' blood test for major depressive disorder, MDDScore, to primary care and pain physicians. Ridge claims the product is the first clinically-available blood test for depression – albeit to a very limited market for now – and CEO Lonna Williams told Clinica the company hasn't "seen anything else on the horizon".





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts